Long-Term Side Effects of Apple Cider Vinegar
While apple cider vinegar may offer some metabolic benefits, long-term consumption carries documented risks including dental erosion, hepatotoxicity, and gastrointestinal damage, particularly at higher doses.
Primary Safety Concerns
Hepatotoxicity (Liver Damage)
The most serious documented long-term side effect is idiosyncratic drug-induced liver injury. A recent case report 1 describes a 60-year-old man who developed hepatotoxicity after prolonged vinegar consumption, which resolved after discontinuation. This represents a rare but clinically significant risk that clinicians should monitor for in patients using ACV chronically.
Dental Erosion
Chronic consumption causes erosive tooth wear, particularly concerning in individuals using ACV for weight loss 2. A case of a 15-year-old girl who consumed daily apple cider vinegar developed significant dental erosion. This is especially problematic because:
- The practice is culturally transmitted in some populations (North African communities)
- Bodybuilders commonly use this method for weight reduction
- The acidic nature directly damages tooth enamel with repeated exposure
Gastrointestinal and Organ Damage
Animal studies reveal dose-dependent tissue damage 3:
- Gastric mucosa erosion at higher doses
- Vacuolated hepatocytes (liver cell damage)
- Duodenal villus blunting
- Dilatation of gastric glands
These histopathological changes occurred specifically in high-dose groups, suggesting a clear dose-response relationship for toxicity.
Dose-Dependent Effects
The evidence indicates that dosage is critical for both benefits and harms:
- Lower doses (≤10 mL/day): Generally well-tolerated with potential metabolic benefits 4, 5
- Higher doses: Associated with organ damage, increased liver enzymes (alkaline phosphatase elevation), and tissue pathology 3
Animal studies showed that doses of 0.51 ml/kg and 1.02 ml/kg body weight caused significant adverse effects including increased liver and spleen weight, suggesting organ stress 3.
Metabolic Effects vs. Safety Profile
While systematic reviews show ACV can reduce fasting blood glucose (-21.20 mg/dL) and HbA1c (-0.91 mg/dL) in diabetic patients 6, these potential benefits must be weighed against documented safety risks. The 2020 systematic review concluded that "the risk of side effects when ingested in recommended quantities and in recommended ways seems inconsiderable" 4, but emphasized that evidence quality is insufficient for definitive conclusions.
Clinical Recommendations
If patients insist on using ACV:
- Limit consumption to ≤10 mL/day (approximately 2 teaspoons)
- Always dilute in water (never consume undiluted)
- Use a straw to minimize dental contact
- Monitor liver function tests if using long-term (>12 weeks)
- Rinse mouth with water after consumption
- Avoid in patients with pre-existing liver disease or gastroesophageal reflux
Critical Caveats
The evidence base has significant limitations 4:
- Most human studies are small-scale and short-term
- High risk of bias in many included trials
- Long-term safety data (>6 months) is essentially absent
- Individual susceptibility to hepatotoxicity cannot be predicted
The documented cases of hepatotoxicity 1 and dental erosion 2 represent real clinical consequences that outweigh the modest and inconsistent metabolic benefits, particularly when safer, evidence-based interventions exist for glycemic control and weight management.